Table 1 Characteristics of dogs with hemangiosarcoma utilized for mechanism of action evaluation
Patient | Breed | Age (y) | Sex/Statusb | Weight (kg) | Primary | Metastasis |
|---|---|---|---|---|---|---|
16–034 | Mixed | 6 | F/S | 12.2 | Subcutaneous | No |
18–082 | Golden retriever | NRa | M/C | 40.9 | Liver | Yes |
19–039 | Mixed | 12 | M/C | 36.2 | Subcutaneous | No |
19–060 | Boxer | 7 | M/I | 29.5 | Subcutaneous | No |
19–195 | Rottweiler | 3 | F/S | 34.9 | Bonec | No |
19–199 | Labrador retriever | 12 | M/C | NR | Spleen | No |
19–261 | Golden retriever | 10 | F/S | 25.9 | Spleen | No |
20−008 | Mixed | NR | M/C | 12.2 | Spleen | No |
20−010 | Coonhound | 7 | F/S | 31.8 | Spleen | No |
20–020 | Mixed | 13 | M/C | 22.7 | Subcutaneous | No |
20–025 | English Setter | 14 | M/C | 31.6 | Spleen | No |
20–027 | Mixed | 10 | M/C | 24.0 | Spleen | No |
20–040 | Mixed | 10 | M/C | 41.5 | Spleen | Yes |